Serum hs-CRP was correlated with treatment response to pegylated interferon and ribavirin combination therapy in chronic hepatitis C patients

Hepatology International

Volumn 4, Issue 3, 2010, Pages 621-627

  Huang, Chung Feng ^a   Hsieh, Ming Yen ^a   Yang, Jeng Fu ^a   Chen, Wu Cheng ^a   Yeh, Ming Lun ^a,b   Huang, Ching I ^a,b   Dai, Chia Yen ^a,b   Yu, Ming Lung ^a,b   Lin, Zu Yau ^a,b   Chen, Shinn Chern ^a,b   Chuang, Wan Long ^a,b   Huang, Jee Fu ^a,b  

^a KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Antiviral therapy; Hepatitis C virus; High sensitivity C reactive protein

Indexed keywords

C REACTIVE PROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PEGINTERFERON ALPHA2A; RIBAVIRIN;

ADULT; ANTIVIRAL THERAPY; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG RESPONSE; FEMALE; HEPATITIS C; HISTOPATHOLOGY; HUMAN; LIVER BIOPSY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

EID: 77958086600     PISSN: 19360533     EISSN: 19360541     Source Type: Journal    
DOI: 10.1007/s12072-010-9200-8     Document Type: Article

References (40)

1. C Mazzaro G Panarello F Tesio G Santini M Crovatto G Mazzi F Zorat P Tulissi E Pussini S Baracetti L Campanacci G Pozzato 2000 Hepatitis C virus risk: a hepatitis C virus related syndrome J Intern Med 247 535 545 1:STN:280:DC%2BD3c3ntVejsw%3D%3D 10.1046/j.1365-2796.2000.00627.x 10809992 (Pubitemid 30318056)
2. JF Huang WL Chuang CY Dai CK Ho SJ Hwang SC Chen ZY Lin LY Wang WY Chang ML Yu 2006 Viral hepatitis and proteinuria in an area endemic for hepatitis B and C infections: another chain of link? J Intern Med 260 255 262 10.1111/j.1365-2796.2006.01686.x 16918823 (Pubitemid 44253639)
3. JF Huang CY Dai SJ Hwang CK Ho PJ Hsiao MY Hsieh LP Lee ZY Lin SC Chen LY Wang SJ Shin WY Chang WL Chuang ML Yu 2007 Hepatitis C viremia increases the association with type 2 diabetes mellitus in a hepatitis B and C endemic area: an epidemiological link with virological implication Am J Gastroenterol 102 1237 1243 10.1111/j.1572-0241.2007.01181.x 17531012 (Pubitemid 46802026)
4. JF Huang WL Chuang ML Yu SH Yu CF Huang CI Huang ML Yeh MH Hsieh JF Yang ZY Lin SC Chen CY Dai WY Chang 2009 Hepatitis C virus infection and metabolic syndrome-a community-based study in an endemic area of Taiwan Kaohsiung J Med Sci 25 299 305 10.1016/S1607-551X(09)70520-0 19560994
5. ML Yu WL Chuang 2009 Treatment of chronic hepatitis C in Asia: when East meets West J Gastroenterol Hepatol 24 336 345 1:CAS:528:DC%2BD1MXltFCgtL8%3D 10.1111/j.1440-1746.2009.05789.x 19335784
6. MY Hsieh CY Dai LP Lee JF Huang WC Tsai NJ Hou ZY Lin SC Chen LY Wang WY Chang WL Chuang ML Yu 2008 Antinuclear antibody is associated with a more advanced fibrosis and lower RNA levels of hepatitis C virus in patients with chronic hepatitis C J Clin Pathol 61 333 337 1:CAS:528:DC%2BD1cXkt1yjtrs%3D 10.1136/jcp.2006.046276 17545561 (Pubitemid 351354240)
7. T Kawaguchi T Yoshida M Harada T Hisamoto Y Nagao T Ide E Taniguchi H Kumemura S Hanada M Maeyama S Baba H Koga R Kumashiro T Ueno H Ogata A Yoshimura M Sata 2004 Hepatitis C virus down-regulates insulin receptor substrates 1 and 2 through up-regulation of suppressor of cytokine signaling 3 Am J Pathol 165 1499 1508 1:CAS:528:DC%2BD2cXhtVCgsLfI 15509521
8. CY Dai WL Chuang CK Ho MY Hsieh JF Huang LP Lee NJ Hou ZY Lin SC Chen MY Hsieh LY Wang JF Tsai WY Chang ML Yu 2008 Associations between hepatitis C viremia and low serum triglyceride and cholesterol levels: a community-based study J Hepatol 49 9 16 1:CAS:528:DC%2BD1cXmvFelsL8%3D 10.1016/j.jhep.2008.03. 016 18486265
9. Kilic T, Jneid H, Ural E, Oner G, Sahin T, Kozdag G, Kahraman G, Ural D. Impact of the metabolic syndrome on high-sensitivity C reactive protein levels in patients with acute coronary syndrome. Atherosclerosis 2009;207:591-596
10. W Koenig N Khuseyinova J Baumert C Meisinger 2008 Prospective study of high-sensitivity C-reactive protein as a determinant of mortality: results from the MONICA/KORA Augsburg Cohort Study, 1984-1998 Clin Chem 54 335 342 1:CAS:528:DC%2BD1cXhs1Cmu70%3D 10.1373/clinchem.2007.100271 18156284 (Pubitemid 351302620)
11. PM Ridker JE Buring NR Cook N Rifai 2003 C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14 719 initially healthy American women Circulation 107 391 397 10.1161/01.CIR.0000055014.62083.05 12551861
12. JS Yudkin CD Stehouwer JJ Emeis SW Coppack 1999 C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue? Arterioscler Thromb Vasc Biol 19 972 978 1:CAS:528:DyaK1MXislaru70%3D 10195925
13. B Zethelius L Berglund J Sundstrom E Ingelsson S Basu A Larsson P Venge J Arnlov 2008 Use of multiple biomarkers to improve the prediction of death from cardiovascular causes N Engl J Med 358 2107 2116 1:CAS:528:DC%2BD1cXlvFCrsrw%3D 10.1056/NEJMoa0707064 18480203 (Pubitemid 351679597)
14. J Zacho A Tybjaerg-Hansen JS Jensen P Grande H Sillesen BG Nordestgaard 2008 Genetically elevated C-reactive protein and ischemic vascular disease N Engl J Med 359 1897 1908 1:CAS:528:DC%2BD1cXhtlaitbbE 10.1056/NEJMoa0707402 18971492
15. I Kushner 1982 The phenomenon of the acute phase response Ann NY Acad Sci 389 39 48 1:CAS:528:DyaL38XkvV2ku7c%3D 10.1111/j.1749-6632.1982.tb22124.x 7046585
16. L Kalabay E Nemesanszky A Csepregi M Pusztay K David G Horvath E Ibranyi L Telegdy A Par A Biro B Fekete J Gervain M Horanyi P Ribiczey M Csondes M Kleiber S Walentin Z Prohaszka G Fust 2004 Paradoxical alteration of acute-phase protein levels in patients with chronic hepatitis C treated with IFN-alpha2b Int Immunol 16 51 54 1:CAS:528:DC%2BD2cXmsVyj 10.1093/intimm/dxh024 14688060 (Pubitemid 38054626)
17. JI Tsui MA Whooley A Monto K Seal PC Tien M Shlipak 2009 Association of hepatitis C virus seropositivity with inflammatory markers and heart failure in persons with coronary heart disease: data from the Heart and Soul study J Card Fail 15 451 456 1:CAS:528:DC%2BD1MXms1ygs7w%3D 10.1016/j.cardfail.2008.12.003 19477406
18. J Reingold C Wanke D Kotler C Lewis R Tracy S Heymsfield P Tien P Bacchetti R Scherzer C Grunfeld M Shlipak 2008 Association of HIV infection and HIV/HCV coinfection with C-reactive protein levels: the fat redistribution and metabolic change in HIV infection (FRAM) study J Acquir Immune Defic Syndr 48 142 148 1:CAS:528:DC%2BD1cXmsF2jtrg%3D 10.1097/QAI.0b013e3181685727 18344877
19. M Floris-Moore AA Howard Y Lo EE Schoenbaum JH Arnsten RS Klein 2007 Hepatitis C infection is associated with lower lipids and high-sensitivity C-reactive protein in HIV-infected men AIDS Patient Care STDS 21 479 491 10.1089/apc.2006.0150 17651029 (Pubitemid 47221643)
20. B Yelken N Gorgulu Y Caliskan A Elitok AO Cimen H Yazici H Oflaz A Turkmen MS Sever 2009 Association between chronic hepatitis C infection and coronary flow reserve in dialysis patients with failed renal allografts Transplant Proc 41 1519 1523 1:STN:280:DC%2BD1Mvjs1SksA%3D%3D 10.1016/j.transproceed.2009.03.069 19545669
21. MM Nascimento A Bruchfeld ME Suliman SY Hayashi R Pecoits-Filho RC Manfro MA Pachaly L Renner P Stenvinkel MC Riella B Lindholm 2005 Effect of hepatitis C serology on C-reactive protein in a cohort of Brazilian hemodialysis patients Braz J Med Biol Res 38 783 788 1:CAS:528:DC%2BD2MXmtFGqt7c%3D 10.1590/S0100-879X2005000500017 15917961
22. H Okamoto H Tokita M Sakamoto M Horikita M Kojima H Iizuka S Mishiro 1993 Characterization of the genomic sequence of type V (or 3a) hepatitis C virus isolates and PCR primers for specific detection J Gen Virol 74 2385 2390 1:CAS:528:DyaK2cXhvVChtr8%3D 10.1099/0022-1317-74-11-2385 7504073
23. DK Lahiri JI Nurnberger Jr 1991 A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies Nucleic Acids Res 19 5444 1:CAS:528:DyaK3MXmslalsLw%3D 10.1093/nar/19.19.5444 1681511
24. S Black I Kushner D Samols 2004 C-reactive Protein J Biol Chem 279 48487 48490 1:CAS:528:DC%2BD2cXpslGqtrw%3D 10.1074/jbc.R400025200 15337754 (Pubitemid 39625721)
25. P Libby PM Ridker 2004 Inflammation and atherosclerosis: role of C-reactive protein in risk assessment Am J Med 116 9S 16S 10.1016/j.amjmed.2004. 02.006 15050187 (Pubitemid 38402010)
26. A Riquelme M Arrese A Soza A Morales R Baudrand RM Perez-Ayuso R Gonzalez M Alvarez V Hernandez MJ Garcia-Zattera F Otarola B Medina A Rigotti JF Miquel G Marshall F Nervi 2009 Non-alcoholic fatty liver disease and its association with obesity, insulin resistance and increased serum levels of C-reactive protein in Hispanics Liver Int 29 82 88 1:CAS:528:DC%2BD1MXhvVGmtLs%3D 10.1111/j.1478-3231.2008.01823.x 18647235
27. T Kogiso Y Moriyoshi S Shimizu H Nagahara K Shiratori 2009 High-sensitivity C-reactive protein as a serum predictor of nonalcoholic fatty liver disease based on the Akaike Information Criterion scoring system in the general Japanese population J Gastroenterol 44 313 321 1:CAS:528: DC%2BD1MXkt1yitb8%3D 10.1007/s00535-009-0002-5 19271113
28. BB Duncan MI Schmidt JS Pankow CM Ballantyne D Couper A Vigo R Hoogeveen AR Folsom G Heiss 2003 Low-grade systemic inflammation and the development of type 2 diabetes: the atherosclerosis risk in communities study Diabetes 52 1799 1805 1:CAS:528:DC%2BD3sXltlWhur4%3D 10.2337/diabetes.52.7.1799 12829649
29. Y Shintani H Fujie H Miyoshi T Tsutsumi K Tsukamoto S Kimura K Moriya K Koike 2004 Hepatitis C virus infection and diabetes: direct involvement of the virus in the development of insulin resistance Gastroenterology 126 840 848 1:CAS:528:DC%2BD2cXivFCisLw%3D 10.1053/j.gastro.2003.11.056 14988838 (Pubitemid 38298332)
30. M Yoneda S Saito T Ikeda K Fujita H Mawatari H Kirikoshi M Inamori Y Nozaki T Akiyama H Takahashi Y Abe K Kubota T Iwasaki Y Terauchi S Togo A Nakajima 2007 Hepatitis C virus directly associates with insulin resistance independent of the visceral fat area in nonobese and nondiabetic patients J Viral Hepat 14 600 607 1:STN:280:DC%2BD2svotVyhsg%3D%3D 10.1111/j.1365-2893. 2006.00836.x 17697011 (Pubitemid 47258260)
31. JF Huang ML Yu CY Dai MY Hsieh SJ Hwang PJ Hsiao LP Lee ZY Lin SC Chen MY Hsieh LY Wang SJ Shin WY Chang WL Chuang 2008 Reappraisal of the characteristics of glucose abnormalities in patients with chronic hepatitis C infection Am J Gastroenterol 103 1933 1940 1:CAS:528:DC%2BD1cXhtFGhur3K 10.1111/j.1572-0241.2008.01996.x 18637090
32. CY Dai JF Huang MY Hsieh NJ Hou ZY Lin SC Chen LY Wang WY Chang WL Chuang ML Yu 2009 Insulin resistance predicts response to peginterferon-alpha/ ribavirin combination therapy in chronic hepatitis C patients J Hepatol 50 712 718 1:CAS:528:DC%2BD1MXjt1Khsb4%3D 10.1016/j.jhep.2008.12.017 19231011
33. N Oyake T Shimada Y Murakami Y Ishibashi H Satoh K Suzuki A Matsumory T Oda 2008 Hepatitis C virus infection as a risk factor for increased aortic stiffness and cardiovascular events in dialysis patients J Nephrol 21 345 353 1:CAS:528:DC%2BD1MXjs1ahsQ%3D%3D 18587722
34. M Moritani K Adachi N Arima T Takashima Y Miyaoka M Niigaki K Furuta S Sato Y Kinoshita 2005 A study of arteriosclerosis in healthy subjects with HBV and HCV infection J Gastroenterol 40 1049 1053 10.1007/s00535-005-1655-3 16322949 (Pubitemid 43055289)
35. N Ishizaka Y Ishizaka E Takahashi E Tooda H Hashimoto R Nagai M Yamakado 2002 Association between hepatitis C virus seropositivity, carotid-artery plaque, and intima-media thickening Lancet 359 133 135 10.1016/S0140-6736(02) 07339-7 11809259 (Pubitemid 34112545)
36. M Monazahian I Bohme S Bonk A Koch C Scholz S Grethe R Thomssen 1999 Low density lipoprotein receptor as a candidate receptor for hepatitis C virus J Med Virol 57 223 229 1:CAS:528:DyaK1MXhtlShsLs%3D 10.1002/(SICI)1096-9071(199903) 57:3<223::AID-JMV2>3.0.CO;2-4 10022791 (Pubitemid 29069727)
37. V Agnello G Abel M Elfahal GB Knight QX Zhang 1999 Hepatitis C virus and other flaviviridae viruses enter cells via low density lipoprotein receptor Proc Natl Acad Sci USA 96 1276 10.1073/pnas.96.22.12766 (Pubitemid 29513577)
38. Ramadori G, Armbrust T. Cytokines in the liver. Eur J Gastroenterol Hepatol 2001;13:777-784
39. Biro L, Varga L, Par A, Nemesanszky E, Csepregi A, Telegdy L, Ibranyi E, David K, Horvath G, Szentgyorgyi L, Nagy I, Dalmi L, Abonyi M, Fust G, Horanyi M. Changes in the acute phase complement component and IL-6 levels in patients with chronic hepatitis C receiving interferon alpha-2b. Immunol Lett 2000;72:69-74
40. Keeffe EB. Chronic hepatitis C: management of treatment failures. Clin Gastroenterol Hepatol 2005;3:S102-S105